Jose L. Casado
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 10, 2025
Neuropsychiatric Tolerability of Long-Acting Cabotegravir and Rilpivirine in People With HIV With Prior INSTI-Related CNS Toxicity: A Real-World Cohort Study.
Journal: Open forum infectious diseases
Published: November 20, 2025
Urinary exosome-derived microRNAs as biomarkers of tenofovir disoproxil fumarate (TDF)-induced renal toxicity in people with HIV-1.
Journal: International journal of antimicrobial agents
Published: July 17, 2025
Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution.
Journal: Vaccines
Published: May 06, 2025
From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV.
Journal: The Journal of antimicrobial chemotherapy
Published: April 01, 2025
Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study.
Journal: HIV medicine
Published: March 30, 2025
Long-Acting Cabotegravir and Rilpivirine in Patients With HIV With Solid Organ Transplantation: A Case Series.
Journal: Open forum infectious diseases
Published: March 03, 2025
Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 09, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.
Journal: The lancet. HIV
Published: July 12, 2024
A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: March 31, 2023
Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people with HIV.
Journal: AIDS (London, England)
Published: February 13, 2023
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination.
Journal: Viruses
Published: January 18, 2023
Last Updated: 09/26/2026